It is a infrastructure and utilities private limited company based in Secunderabad, Telangana, India, established in 2014.
2014 | Secunderabad, Telangana, India | ActiveSynapse Drugs Private Limited, a active private limited company, was established on 03 December 2014 in Secunderabad, Telangana, India. Engaging in general construction services within the manufacturing sector, it holds CIN: U24232TG2014PTC096661. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sucharitha Vala (Additional Director), Niranjanrao Janardhanrao Errabelli (Director), Venkata Narasimha Rao Vala (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No. 1-8-309/1, Flat No. 205 Lake View Residency, Patigadda, Secunderabad, Telangana, 500003.
U24232TG2014PTC096661
096661
03 December 2014
₹0.50 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Synapse Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sucharitha Vala | Additional Director | 01 May 2019 | Current |
| Niranjanrao Janardhanrao Errabelli | Director | 03 Dec 2014 | Current |
| Venkata Narasimha Rao Vala | Director | 03 Dec 2014 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Synapse Drugs Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2019, Synapse Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Synapse Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Synapse Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synapse Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Synapse Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Synapse Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Sucharitha Vala was appointed as a Additional Director was appointed as a Additional Director on 01 May 2019 & has been associated with this company since 6 years 7 months . was recorded as a recent event.
Niranjanrao Janardhanrao Errabelli was appointed as a Director was appointed as a Director on 03 Dec 2014 & has been associated with this company since 10 years 11 months . was recorded as a recent event.
The activity Venkata Narasimha Rao Vala was appointed as a Director was appointed as a Director on 03 Dec 2014 & has been associated with this company since 10 years 11 months . was completed.
Synapse Drugs Private Limited was registered on 03 Dec 2014 with Roc Hyderabad & aged 10 years 11 months as per MCA records. was recorded as a recent event.
The CIN of Synapse Drugs Private Limited is U24232TG2014PTC096661.
Synapse Drugs Private Limited is headquartered at H.No. 1-8-309/1, Flat No. 205 Lake View Residency, Patigadda, Secunderabad, Telangana, 500003.
Synapse Drugs Private Limited was incorporated on 03 December 2014.
The current directors of Synapse Drugs Private Limited are
The primary industry of Synapse Drugs Private Limited is Manufacturing.
Synapse Drugs Private Limited is unlisted.
The authorized capital of Synapse Drugs Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Synapse Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX